Pristiq - 0008-1222-01 - (DESVENLAFAXINE SUCCINATE)

Alphabetical Index


Drug Information of Pristiq

Product NDC: 0008-1222
Proprietary Name: Pristiq
Non Proprietary Name: DESVENLAFAXINE SUCCINATE
Active Ingredient(s): 100    mg/1 & nbsp;   DESVENLAFAXINE SUCCINATE
Administration Route(s): ORAL
Dosage Form(s): TABLET, EXTENDED RELEASE
Coding System: National Drug Codes(NDC)

Labeler Information of Pristiq

Product NDC: 0008-1222
Labeler Name: Wyeth Pharmaceuticals Company, a subsidiary of Pfizer Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA021992
Marketing Category: NDA
Start Marketing Date: 20080501

Package Information of Pristiq

Package NDC: 0008-1222-01
Package Description: 90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0008-1222-01)

NDC Information of Pristiq

NDC Code 0008-1222-01
Proprietary Name Pristiq
Package Description 90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0008-1222-01)
Product NDC 0008-1222
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name DESVENLAFAXINE SUCCINATE
Dosage Form Name TABLET, EXTENDED RELEASE
Route Name ORAL
Start Marketing Date 20080501
Marketing Category Name NDA
Labeler Name Wyeth Pharmaceuticals Company, a subsidiary of Pfizer Inc.
Substance Name DESVENLAFAXINE SUCCINATE
Strength Number 100
Strength Unit mg/1
Pharmaceutical Classes Norepinephrine Uptake Inhibitors [MoA],Serotonin and Norepinephrine Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA]

Complete Information of Pristiq


General Information